CTKB - Cytek Biosciences, Inc.

QQQ $ 439.55 $ -0.26 (-0.06 %)

DIA $ 390.50 $ 1.74 (0.45 %)

SPY $ 517.10 $ 0.05 (0.01 %)

TLT $ 90.18 $ -0.55 (-0.61 %)

GLD $ 213.58 $ -0.63 (-0.29 %)

Previous Close

$ 6.27

Open

$ 6.30

Bid

$ 6.26 x 200

Ask

$ 0.00 x 0

Day's Range

$ 6.24 - $ 6.33

52 Week Range

$ 3.80 - $ 11.71

Volume

329,300

Average Volume

Market Cap

820.87M

Beta (5Y Monthly)

$ 1.11

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-08-2024	03-31-2024	10-Q
2	03-13-2024	12-31-2023	10-K
3	11-14-2023	09-30-2023	10-Q
4	08-08-2023	06-30-2023	10-Q
5	05-09-2023	03-31-2023	10-Q
6	03-01-2023	12-31-2022	10-K
7	11-09-2022	09-30-2022	10-Q
8	08-10-2022	06-30-2022	10-Q
9	05-11-2022	03-31-2022	10-Q
10	03-17-2022	12-31-2021	10-K
11	11-12-2021	09-30-2021	10-Q
12	09-02-2021	06-30-2021	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Cytek Biosciences Q1 2024 Adj EPS $(0.05) ...
05/08/2024 20:08:59

Cytek Biosciences (NASDAQ:CTKB) reported quarterly losses of $(0.05) per share which missed the analyst consensus estimate of $...

Cytek Biosciences Names William McCombe Ch...
03/19/2024 12:06:33

Experienced executive with extensive background as CFO for global corporations across dynamic sectors Cytek reaffirms 2024 outl...

Cytek Biosciences Opens New 50,000-Square-...
03/07/2024 22:32:01

Piper Sandler Maintains Overweight on Cyte...
03/06/2024 14:30:42

Piper Sandler analyst David Westenberg maintains Cytek Biosciences (NASDAQ:CTKB) with a Overweight and lowers the price targ...

Tesla, Spirit Airlines, New York Community...
03/04/2024 15:40:18

U.S. stocks were lower, with the Dow Jones index falling around 80 points on Monday.

Cytek Biosciences Inc Files For Non-Timely...
03/01/2024 21:14:01

- SEC Filing

why-butterfly-network-shares-are-trading-lower-by-22-here-are-other-stocks-moving-in-thursdays-mid-day-session

Why Butterfly Network Shares Are Trading L...
02/29/2024 19:00:01

Shares of Butterfly Network, Inc. (NASDAQ: BFLY) fell sharply during Thursday’s session after the company reported mixed four...

Goldman Sachs Maintains Buy on Cytek Biosc...
02/29/2024 14:56:06

Goldman Sachs analyst Matthew Sykes maintains Cytek Biosciences (NASDAQ:CTKB) with a Buy and raises the price target from $9...

Cytek Biosciences Expects 2024 Total Reven...
02/28/2024 22:29:57

Cytek Biosciences Q4 Sales $58.60M Beat $5...
02/28/2024 22:11:02

Cytek Biosciences (NASDAQ:CTKB) reported quarterly sales of $58.60 million which beat the analyst consensus estimate of $56.58 ...

Earnings Scheduled For February 28, 2024
02/28/2024 11:24:02

Companies Reporting Before The Bell • ICL Group (NYSE:ICL) is likely to report quarterly earnings at $0.08 per share on revenu...

Cytek Biosciences Inks Agreement With Cent...
01/17/2024 22:32:22

Under the terms of the agreement, Cytek will provide new, state-of-the-art spectral cytometry platforms – along with trained su...

Cytek Biosciences Expects Its FY23 Revenue...
01/08/2024 14:30:14

Cytek Biosciences, Inc. (NASDAQ:CTKB), a leading cell analysis solutions company, today announced preliminary, unaudited revenu...

Cytek Biosciences Introduces The Cytek Ori...
12/21/2023 14:07:48

Cytek Biosciences, Inc. (NASDAQ:CTKB), a leading cell analysis solutions company, announced today the introduction of the Cytek...

cyteks-full-spectrum-technology-stands-out-in-cell-analysis-market-bullish-analyst-says

Cytek's Full Spectrum Technology Stands Ou...
12/14/2023 19:26:48

Stephens initiated coverage on Cytek Biosciences Inc (NASDAQ: CTKB), a manufacturer and supplier of flow cytometry products and...

The Latest Analyst Ratings for Cytek Biosc...
12/14/2023 16:00:20

Stephens & Co. Initiates Coverage On Cytek...
12/14/2023 10:46:26

Stephens & Co. analyst Mason Carrico initiates coverage on Cytek Biosciences (NASDAQ:CTKB) with a Overweight rating and ...

Morgan Stanley Maintains Equal-Weight on C...
11/09/2023 14:02:33

Morgan Stanley analyst Tejas Savant maintains Cytek Biosciences (NASDAQ:CTKB) with a Equal-Weight and lowers the price targe...

Cytek Biosciences shares are trading lower...
11/08/2023 14:13:31

12-health-care-stocks-moving-in-wednesdays-pre-market-session

12 Health Care Stocks Moving In Wednesday'...
11/08/2023 13:06:41